AstraZeneca and MAP Collaborate for Development and Commercialization of Unit Dose Budesonide

News   Dec 22, 2008

 
AstraZeneca and MAP Collaborate for Development and Commercialization of Unit Dose Budesonide
 
 
 
FURTHER INFORMATION
 

This content appears on:

Drug Discovery

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Comments | 0 ADD COMMENT